Riskpilot← Back to searchSign inGet full accessPalvadent Oy
OYDissolvedY-tunnus 2816426-9Helenankuja 4-AMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2025
EUR 287K
+5% vs 2024
EBITDA margin
-25.7%
-204% vs 2024
Equity ratio
95.3%
Financial strength
Net profit 2025
EUR 33K
-90% vs 2024
| Revenue | EUR 287K | +5% |
| EBITDA | EUR -74K | -204% |
| Net profit | EUR 33K | -90% |
| Total assets | EUR 702K | -10% |
| Equity | EUR 669K | -6% |
| Employees | 0 | — |
Legal name
Palvadent Oy
Y-tunnus number
2816426-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
16. helmikuuta 2017
Share capital
EUR 2 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on hammaslääkäri- ja muiden terveydenhoitoalan palvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, työnohjauspalvelujen tuottaminen, luennointi sekä tutkimus- ja tuotekehityspalvelut ja kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Helenankuja 4-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 18 | 103 | 273 | 287 |
| Staff expenses | — | — | −40 | −16 | −159 |
| EBITDA | −0 | 13 | −26 | 71 | −74 |
| Depreciation & amort. | — | — | −0 | −23 | −18 |
| EBIT | −0 | 13 | −27 | 48 | −91 |
| Net financials | — | 765 | 58 | 272 | 119 |
| Profit before tax | −0 | 778 | 31 | 320 | 28 |
| Tax | −0 | 3 | 5 | 3 | −5 |
| Net profit | −0 | 775 | 26 | 316 | 33 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 157 | 783 | 764 | 777 | 702 |
| Equity | 0 | 775 | 740 | 712 | 669 |
| Long-term debt | 150 | — | 0 | 0 | 30 |
| Short-term debt | 6 | 7 | 24 | 66 | 3 |
| Total debt | 156 | 7 | 24 | 66 | 3 |
EBITDA margin
-25.7%
This company
15.8%
Market median
-263% vs market
20212025
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20212025
Return on equity
4.9%
This company
18.4%
Market median
-73% vs market
20212025
Net profit margin
11.5%
This company
8.1%
Market median
+42% vs market
20212025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Deputy Member | Deputy Member | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Palvadent Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsi Anneli Palva | Deputy Member | 0 companies |
| Otto Akseli Palva | Board of Directors | 0 companies |